financetom
Business
financetom
/
Business
/
Grab Q3 Earnings Flat, Revenue Rises; Annual Sales Outlook Revised -- Shares Down Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Grab Q3 Earnings Flat, Revenue Rises; Annual Sales Outlook Revised -- Shares Down Pre-Bell
Nov 4, 2025 2:52 AM

05:43 AM EST, 11/04/2025 (MT Newswires) -- Grab Holdings ( GRAB ) reported Q3 earnings Tuesday of $0.01 per diluted share, unchanged from a year earlier.

Analysts polled by FactSet expected $0.01.

Revenue for the quarter ended Sept. 30 was $873 million, up from $716 million a year earlier.

Analysts surveyed by FactSet expected $873.7 million.

For 2025, the company said it now expects revenue in the range of $3.38 billion to $3.40 billion, compared with its prior guidance of between $3.33 billion and $3.40 billion. Analysts polled by FactSet expect $3.42 billion.

Grab shares were down 6.8% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Inseego Signs Debt Reduction and Restructuring Agreements; Shares Rise
Inseego Signs Debt Reduction and Restructuring Agreements; Shares Rise
Jul 1, 2024
10:46 AM EDT, 07/01/2024 (MT Newswires) -- Inseego ( INSG ) said Monday it signed a series of agreements to manage its capital structure by reducing total debt and restructuring its outstanding 3.25% convertible notes due 2025. The company's three largest noteholders, representing over $125 million of the outstanding 2025 notes, agreed to sell or exchange their holdings for cash,...
Longboard Pharmaceuticals Gets FDA Breakthrough Therapy Designation for Seizure Treatment
Longboard Pharmaceuticals Gets FDA Breakthrough Therapy Designation for Seizure Treatment
Jul 1, 2024
10:46 AM EDT, 07/01/2024 (MT Newswires) -- Longboard Pharmaceuticals ( LBPH ) said Monday the US Food and Drug Administration granted breakthrough therapy designation to its investigational drug bexicaserin to treat seizures associated with developmental and epileptic encephalopathies for patients two years and older. The FDA will work closely with us to provide guidance on subsequent development of bexicaserin to...
What's Going On With Satellite Stock AST SpaceMobile Monday?
What's Going On With Satellite Stock AST SpaceMobile Monday?
Jul 1, 2024
AST SpaceMobile, Inc ( ASTS ) stock is trading higher Monday after Chairman and CEO Abel Avellan published a letter to partners, shareholders, and future space-based cellular broadband network users.  Avellan said the strategic partnership with Verizon Communications Inc ( VZ ) , building on its existing agreement with AT&T Inc ( T ) , aims to eliminate connectivity gaps...
Trading app Robinhood says working to resolve interruption in service
Trading app Robinhood says working to resolve interruption in service
Jul 1, 2024
July 1 (Reuters) - Robinhood said on Monday it was working to resolve an issue that was causing an interruption of service for some users on its trading platform. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved